NDC 69489-212

ZILXI

Minocycline

ZILXI is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Journey Medical Corporation. The primary component is Minocycline Hydrochloride.

• Product ID: 69489-212_ce3a58dd-8637-4647-b094-c19bf5d0ce01
• NDC: 69489-212
• Product Type: Human Prescription Drug
• Proprietary Name: ZILXI
• Generic Name: Minocycline
• Dosage Form: Aerosol, Foam
• Route of Administration: TOPICAL
• Marketing Start Date: 2022-10-01
• Marketing Category: NDA /
• Application Number: NDA213690
• Labeler Name: Journey Medical Corporation
• Substance Name: MINOCYCLINE HYDROCHLORIDE
• Active Ingredient Strength: 15 mg/g
• Pharm Classes: Tetracycline-class Drug [EPC], Tetracyclines [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 69489-212-07

1 CAN in 1 CARTON (69489-212-07) > 7 g in 1 CAN

• Marketing Start Date: 2022-10-01
• NDC Exclude Flag: N
• Sample Package?: Y

Drug Details

NDC Crossover Matching brand name "ZILXI" or generic name "Minocycline"

NDC	Brand Name	Generic Name
69489-212	ZILXI	Minocycline
72356-103	ZILXI	Minocycline
69489-201	AMZEEQ	Minocycline
72356-101	AMZEEQ	Minocycline
42291-589	Minocycline	Minocycline
42291-591	Minocycline	Minocycline
49884-511	Minocycline	Minocycline
49884-512	Minocycline	Minocycline
49884-513	Minocycline	Minocycline
63629-2228	Minocycline	Minocycline
63629-2229	Minocycline	Minocycline